HRT Financial
WVE icon

HRT Financial’s Wave Life Sciences WVE Stock Holding History

HRT Financial’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.17M Buy
+1,666,702
New +$8.77M 0.01% 1146
2026
Q2 		– Sell
-321,376
Closed -$2.13M – 5492
2026
Q1 		$2.33M Buy
321,376
+21,658
+7% +$282K 0.01% 1513
2025
Q4 		$5.1M Buy
+299,718
New +$3.05M 0.02% 778
2024
Q1 		– Sell
-14,681
Closed -$74K – 3196
2023
Q4 		$74K Buy
+14,681
New +$78.5K ﹤0.01% 1923
2023
Q2 		– Sell
-233,278
Closed -$1.01M – 3395
2023
Q1 		$1.01M Buy
+233,278
New +$1.07M 0.01% 939
2021
Q2 		– Sell
-11,753
Closed -$65K – 3627
2021
Q1 		$65K Buy
+11,753
New +$113K ﹤0.01% 2513

Other funds holding WVE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
M28 Capital Management
M28 Capital Management Stamford, Connecticut $36M AUM 11.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

HRT Financial's WVE Position: Q3 2026 in Review

HRT Financial opened a new position in Wave Life Sciences (WVE) in Q3 2026: 1,666,702 shares worth $6.17M. The stake represents 0.01% of the portfolio and ranks #1146 among its holdings. This is a return to the name: HRT Financial previously reported a position in WVE as recently as Q1 2026.

HRT Financial first reported a position in WVE in Q1 2021 and has held it in 6 quarters since. 149 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • HRT Financial held 1,666,702 shares of Wave Life Sciences worth $6.17M as of Q3 2026.
  • Wave Life Sciences was a new HRT Financial position in Q3 2026.
  • Wave Life Sciences made up 0.01% of HRT Financial's portfolio in Q3 2026, its #1146 holding.
  • HRT Financial first reported a position in Wave Life Sciences in Q1 2021 and has held it in 6 quarters since.
  • 149 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.